CHARM Therapeutics is an innovative company at the forefront of medicine, specializing in the development of transformational medicines through 3D deep learning and advanced drug discovery technologies. Utilizing their proprietary DragonFold technology, they focus on the previously undruggable disease targets by leveraging revolutionary insights in 3D protein-ligand co-folding. With their state-of-the-art lab facilities, CHARM Therapeutics aims to address high unmet medical needs by creating novel small molecule inhibitors targeting cancers and other conditions. Their groundbreaking efforts are inspired by the work of co-founder David Baker, a Wiley Prize winner, enhancing the rapid and accurate development of treatments.